AzTrials
AzTrials

CGFNCT03992573

CGF Influence on Post-operative Complications.

A study testing CGF application in people with CGF and Bone Loss, run by Medical University of Lodz at 1 site in Poland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of the study is to evaluate the influence of CGF application into post-operative soft tissue and bone defects on post-operative complications and wound healing. Read more about this study

Who is it for?
Ages 18 to 90 yearsHealthy volunteers can take part
Conditions the study is for
CGF, Bone Loss, Post-operative Wound Healing
What is being tested?
CGF application
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 sitePoland
Study dates
1 Oct 2017to 1 Jun 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • no known medical history of abnormal platelet counts,
  • patients with symmetric teeth qualified for extraction,

Who cannot join

  • systemic diseases,
  • pregnancy,
  • lactation,
  • drugs known to affect the number or function of platelets,
  • abnormal platelet counts

Trial locations and contacts

1 site in 1 country.

Poland1 site, 1 recruiting
  • Department of Oral Surgery

    Lodz, 92-213

    Anna Janas-Naze, Prof., +48601229495, anna.janas@umed.lodz.pl

    Recruiting

Other trials in Poland

About this study

Official title: The Influence of Concentrated Growth Factors (CGF) Application on Post-operative Complications.

The aim of the study is to evaluate the influence of CGF application into post-operative soft tissue and bone defects on post-operative complications and wound healing.

Read the detailed description

The research was conducted in twenty patients with symmetric single tooth qualified to extraction. On one side of dental arch, post-operative region was field with CGF material, while on the other side it was left to normal healing. In both cases pain, swelling, alveolar osteitis, antibiotics and analgesics intake in post-operative period were evaluated in the first, fourth and seventh day after surgery. Wound healing was assessed seven and thirty days after extraction.

Being tested
CGF application
Medical subject headings
Bone Diseases, Metabolic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CGF applicationProcedure or surgery

    CGF application into post-operative soft tissue and bone defects

Study groups in NCT03992573
Study groupRoleWhat they receive
Study groupExperimentalNot described
Receives: Procedure: CGF application
Control groupNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intensity of pain vs. CGF application

    In order to evaluate the relationship between intensity of pain after surfery and filling the alveolus with platelet-rich plasma, , NRS (Numeric Rating Scale) pain scale is used.

    NRS scale, ranges from 0 to 10; where 0 refers to no pain and 10 refers to most severe pain.

    Measured: 24 hours

Secondary outcomes (1)
  1. Occurrence of swelling

    The presence of swelling was evaluated using zero one system.

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jun 2019
  2. Study start1 Oct 2017
  3. Primary completion1 Mar 2020 (estimated)
  4. Study completion1 Jun 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03992573
Sponsor's protocol ID
0001
Status last verified
Jun 2019
First submitted
18 Jun 2019
Last updated
8 Jul 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing CGF application in people with CGF and Bone Loss, run by Medical University of Lodz at 1 site in Poland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intensity of pain vs. CGF application (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jul 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in